Welcome to our dedicated page for Corteva SEC filings (Ticker: CTVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Corteva, Inc. (NYSE: CTVA), a global pure-play agriculture company focused on seed, crop protection, and digital products and services. Corteva’s filings include current reports on Form 8-K, annual and quarterly reports, and other disclosures that outline its financial condition, segment performance and significant corporate events.
Recent Form 8-K filings show how Corteva reports results of operations and financial condition, furnishing earnings press releases and financial statement schedules for specific quarters. These filings describe performance in the Seed and Crop Protection segments, regional trends, and management’s guidance ranges. Other 8-Ks address material corporate developments, such as the announced plan to separate the company into two independent, publicly traded entities through a tax-free spin-off, and executive leadership changes in the legal function.
Through this filings feed, users can review Corteva’s official disclosures about its planned separation into a crop protection-focused business (referred to as New Corteva) and a seed-focused business (referred to as SpinCo), as well as details on dividends, capital allocation, and research and development investment discussed in furnished materials. The filings also confirm that Corteva’s common stock is registered on the New York Stock Exchange under the symbol CTVA.
Stock Titan enhances these documents with AI-powered summaries that explain the key points of lengthy filings, helping readers quickly understand segment results, guidance updates and major strategic announcements. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, 10-Ks and other forms appear promptly, while specialized views of insider-related forms such as Form 4 allow users to monitor reported transactions by directors and executive officers where available.
Corteva, Inc. (CTVA) furnished its quarterly results update. On November 4, 2025, the company announced consolidated financial results for the quarter ended September 30, 2025 and furnished the materials on a Form 8-K under Item 2.02.
The update includes a press release and financial statement schedules as Exhibits 99.1 and 99.2. The company states these materials are being furnished, not filed, under the Exchange Act. Corteva’s common stock trades on the NYSE under the symbol CTVA.
Corteva, Inc. (CTVA) director reported acquiring 528.9714 units of common stock on 10/31/2025 at $61.44 per share. The filing states these represent stock units acquired under the Issuer's Stock Accumulation and Deferred Compensation Plan for Directors, which are settled on a one-for-one basis in CTVA common stock on a future date selected at the time of the deferral election. Cash compensation deferred into stock units is calculated using the closing price on the date the cash compensation would have been payable.
Following the reported transaction, the director beneficially owns 32,890.9739 shares, held directly. This total includes the acquisition of 82.9204 shares pursuant to dividend reinvestment.
Corteva (CTVA) disclosed a director acquisition on a Form 4. On 10/31/2025, the director acquired 63.0697 stock units at $61.44 under the company’s Stock Accumulation and Deferred Compensation Plan for Directors, which settles one-for-one in CTVA common stock on a future date elected at deferral.
After the transaction, the director beneficially owned 17,464.8998 shares directly. The holdings include 43.4154 shares credited via dividend reinvestment.
Corteva, Inc. announced a plan to separate into two independent, publicly traded companies through a tax-free spin-off. This means the current business would be split so that shareholders ultimately own stock in two separate companies instead of one, using a structure intended to be tax-free for U.S. federal income tax purposes.
The company also said it would host an investor call at 8:30 a.m. Eastern Daylight Time on October 1, 2025 to discuss the separation. During this call, Corteva plans to comment on its expected 2025 financial performance, giving investors additional context on how the business is performing as it prepares for the separation.
Insider transaction summary for Corteva, Inc. (CTVA): On 09/16/2025 David Paul Johnson, Executive Vice President and Chief Financial Officer, had 6,754 shares of Corteva common stock disposed of at a price of $69.88 per share. The filing states the shares were withheld by the issuer to satisfy taxes due upon vesting of previously granted restricted stock units, not an open-market sale. After the transaction the reporting person beneficially owned 58,312.2466 shares, which includes 493.1945 shares acquired through dividend reinvestment.
Insider grants to Corteva SVP and Chief Legal Officer Jennifer Amy Johnson — The Form 4 discloses that on 09/15/2025 Ms. Johnson was granted 4,282 restricted stock units (RSUs) and a non-qualified stock option for 12,418 shares with an exercise price of $70.07. The RSUs vest in three equal annual installments beginning on the grant date and the option likewise vests in three equal annual installments; the option expires on 09/15/2035. Following the transactions, Ms. Johnson directly beneficially owns 4,282 common shares and holds options covering 12,418 shares. The Form 4 was signed under power of attorney on 09/17/2025.
Jennifer Amy Johnson, identified as Senior Vice President and Chief Legal Officer of Corteva, Inc. (CTVA), filed an Initial Statement of Beneficial Ownership reporting the event dated 09/15/2025. The filing indicates no securities are beneficially owned by the reporting person. The Form 3 was signed by an attorney-in-fact, Abigail Jarrell, on behalf of the reporting person on 09/17/2025.
Robert D. King, EVP, Crop Protection Business at Corteva, reported multiple equity transactions on 08/29/2025. He exercised 14,960 non-qualified options with an exercise price of $58.67 and 9,337 options at $62.29, receiving the same number of common shares. On the same date he sold 37,280 shares at a weighted average price of $74.1951, with sale prices ranging $74.17–$74.23. Following these transactions his reported beneficial ownership is 49,262.2876 shares (direct). The filing notes inclusion of 25.3808 shares from dividend reinvestment and provides option vesting/expiration details for the reported grants.
Corteva, Inc. (CTVA) reported a Form 144 notice for the proposed sale of 37,280 common shares through Merrill Lynch on the NYSE with an aggregate market value of $2,765,994.21. The securities listed were acquired through exercises and vesting of stock awards from Corteva between April 4, 2023 and August 29, 2025, with individual lots of 14,960; 9,337; 11,826; 1,092; and 65 shares. The filer represents they have no undisclosed material adverse information about the company and indicates the sales are compensatory in nature for these equity awards. No sales by the same person in the past three months were reported.
Corteva, Inc. (CTVA) disclosed a press release dated